Correlation Between GlaxoSmithKline PLC and Mildef Crete

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Mildef Crete at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Mildef Crete into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Mildef Crete, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Mildef Crete and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Mildef Crete. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Mildef Crete.

Diversification Opportunities for GlaxoSmithKline PLC and Mildef Crete

0.69
  Correlation Coefficient

Poor diversification

The 3 months correlation between GlaxoSmithKline and Mildef is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Mildef Crete in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mildef Crete and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Mildef Crete. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mildef Crete has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Mildef Crete go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Mildef Crete

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to generate 1.13 times more return on investment than Mildef Crete. However, GlaxoSmithKline PLC is 1.13 times more volatile than Mildef Crete. It trades about -0.3 of its potential returns per unit of risk. Mildef Crete is currently generating about -0.4 per unit of risk. If you would invest  3,774  in GlaxoSmithKline PLC ADR on August 30, 2024 and sell it today you would lose (341.00) from holding GlaxoSmithKline PLC ADR or give up 9.04% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Mildef Crete

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Mildef Crete 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mildef Crete has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

GlaxoSmithKline PLC and Mildef Crete Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Mildef Crete

The main advantage of trading using opposite GlaxoSmithKline PLC and Mildef Crete positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Mildef Crete can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mildef Crete will offset losses from the drop in Mildef Crete's long position.
The idea behind GlaxoSmithKline PLC ADR and Mildef Crete pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios